Home
Blog
Features
Sign Up
Try the Demo today!
Home
Market
Reports
Search
Alerts
Ticker
Company Name
Insider Name
Insider Trading Guide
About
Contact Us
Login
Whitley Richard James
Insider Overview
Current Sentiment
Insider Transactions
Email this page »
View:
Company
Gilead Sciences Inc.
Virios Therapeutics, Inc.
Gilead Sciences Inc.
Director
Avg. Two Year Performance
No Purchase Track Record
12%
Avg. Sale Return
6%
Compound
Holdings:
33.06K
shares
Last Three Months: 24-Aug-24 -- 23-Nov-24
0
Net Amount
Buy:
0
--
Sell:
0
--
Sentiment
Company Sentiment
Biotechnology
Drugs
Two Year Chart
24-Nov-22 -- 23-Nov-24
Price ($)
Sentiment
Company Sentiment
Most Recent Insider Transactions